Ozempic Shows Lower Heart Risk Than Mounjaro

Xurve View
Insights:
Packages of Ozempic are stacked on top of a cabinet at the home of Intan Permatasari in Bogor, West Java province, Indonesia, May 13, 2026. REUTERS/Ajeng Dinar Ulfiana

NOVO NORDISK A/S-B reported that its diabetes drug Ozempic delivered a 6% lower risk of cardiovascular events compared to rival treatments. The findings emerged during a Tuesday presentation in Italy at a major medical gathering. The data arrives as drug makers vie for market share in the United States obesity sector.